Dr. Michael McCarthy

Dr. Michael McCarthy, a consultant oncologist at Galway University Hospital, discusses the shocking inequality in access to new cancer drugs for public patients compared to those with private insurance. He outlines the regulatory challenges that allow drugs to be approved yet remain unavailable publicly. Dr. McCarthy highlights specific life-saving medications like dostarlimab that are denied to many and proposes a co-funded early-access program to improve patient outcomes. His insights reveal the urgent need for equitable healthcare in cancer treatment.